Kyu Jun Son

Kyu Jun Son, MD, currently serves as Senior Director of Corporate Development at Convergent Therapeutics, Inc. Since graduating from Tufts University School of Medicine with a Doctor of Medicine (MD) in 2015, Kyu Jun Son has held various leadership positions in the pharmaceutical industry, including Director of New Product Planning at Q32 Bio Inc., and multiple roles at Sanofi Genzyme. At Sanofi, Kyu Jun Son led global marketing initiatives for Libtayo in basal cell carcinoma, contributed to oncology business development and forecasting, and developed strategies for new oncology products. Prior experience includes research at Vanderbilt University and volunteer work in health clinics in Uganda. Kyu Jun Son holds a Bachelor of Arts in Chemistry and Economics from Vanderbilt University.